Patient Voice, • 9/19/25 Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Previous How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Next Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials You Might Also Like Innovating Clinical Outcome Assessments in Rare Disease Trials: Integrating Patient-Centered Measures and Digital Health Technologies How To Prevent Failure in Rare Disease Trials? Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies
Patient Voice, • 9/19/25 Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Previous How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Next Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials You Might Also Like Innovating Clinical Outcome Assessments in Rare Disease Trials: Integrating Patient-Centered Measures and Digital Health Technologies How To Prevent Failure in Rare Disease Trials? Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Patient-Centric Commercialization: Integrating Patient Voices into Market Access Strategies
